Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7609
+0.0091 (1.21%)
May 2, 2025, 10:24 AM EDT - Market open
Cue Biopharma Employees
Cue Biopharma had 41 employees as of December 31, 2024. The number of employees decreased by 12 or -22.64% compared to the previous year.
Employees
41
Change (1Y)
-12
Growth (1Y)
-22.64%
Revenue / Employee
$226,512
Profits / Employee
-$992,049
Market Cap
57.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CUE News
- 16 days ago - Cue Biopharma, Inc. (CUE) Business Update Call (Transcript) - Seeking Alpha
- 17 days ago - Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases - GlobeNewsWire
- 17 days ago - Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering - GlobeNewsWire
- 17 days ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire
- 17 days ago - Cue Biopharma to Host Business Update Call and Webcast - GlobeNewsWire
- 4 weeks ago - Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 5 months ago - Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire